Ukraine, - the sleeping eastern European tiger is about to awaken?
2019 transactional year in Ukraine has been quite slow due to the tectonic political developments in the country, - presidential election, following dissolution and re-election of the Parliament as well as the new government have dramatically changed the country. Relaunch of the most important public authorities is still ongoing and this transition has largely contributed to the very low investment appetite of the major global financial and strategic investors.
Notwithstanding these political turbulences the end of the year was marked by announcement of a landmark and unique transaction in Ukrainian life - science sector by German STADA acquiring a major domestic manufacturer Biopharma from a group of domestic and financial investors (including US private equity house Horizon Capital), - our firm is privileged and delighted to advise on this remarkable transaction!
Full text available via the link
More detailed information by each practice is available via the links: